Minerva Neurosciences
NERV
$2.37
Share price
-0.84%
Change (1 day)
-48.59%
Change (1 year)
Categories
Minerva Neurosciences (NERV) - Cash on Hand
Cash on Hand as of December 2023 : $40.91 M
According to Minerva Neurosciences
's latest financial reports the company has $40.91 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Minerva Neurosciences - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $40.91 M | 13.35% |
| 2022-12-31 | $36.09 M | -40.59% |
| 2021-12-31 | $60.75 M | 139.6% |
| 2020-12-31 | $25.35 M | -44.7% |
| 2019-12-31 | $45.85 M | -47.89% |
| 2018-12-31 | $87.99 M | -31.34% |
| 2017-12-31 | $0.12 B | 54.45% |
| 2016-12-31 | $82.98 M | 157.67% |
| 2015-12-31 | $32.2 M | 73.65% |
| 2014-12-31 | $18.54 M | 919.94% |
| 2013-12-31 | $1.81 M | 807.73% |
| 2012-12-31 | $0.2 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Incyte INCY | $3.65 B | 8,836.22% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $0.74 B | 1,714.36% | 🇺🇸 USA |
 Clovis Oncology CLVS | $58.32 M | 42.55% | 🇺🇸 USA |